Patients with diabetes: problems revealed by medicines use reviews
| Last year, Nuria Laiglesia performed
over 400 medicines use reviews at Alliance pharmacies in Norwich.
In this article, she shares some of her experiences of reviews
with patients who have diabetes |
Patients with type 2 diabetes who do not respond satisfactorily
to diet and exercise after three months are prescribed oral antidiabetic
drugs. A medicines use review is an ideal way to help these patients
take their medicines correctly.
The dosing of most sulphonylureas is linked with breakfast or the first
main meal of the day so I ask patients to tell me when they take their
tablets and if they ever miss any.
I also ask about their eating patterns.
Patients prescribed metformin tds, the drug of first choice
for those who are overweight, should take tablets during or after meals,
corresponding
to breakfast, lunch and dinner. Patients sometimes miss tablets with tds regimens
especially if they go out for lunch or dinner.
I had one patient who had been prescribed a month’s worth of metformin
and did not order a repeat prescription because he thought that he only
needed to take it for a month, like a course of antibiotics. An MUR also
flagged up an elderly patient being prescribed glibenclamide. This presents
a greater risk of hypoglycaemia so I highlighted this patient to the
GP and suggested considering a shorter-acting alternative, such as gliclazide.
An MUR involves asking about side effects. For gastrointestinal disturbances
with metformin, I recommend taking the tablet after food. Patients taking
sulphonylureas can gain weight. If a patient has put on weight, a review
at the GP practice is advisable. For some, weight gain (also a side effect
of rosiglitazone) can lead to non-compliance. On one occasion, I found
a patient attributing numbness in his fingers to side effects rather
than linking this to diabetic neuropathy and a need to see his GP or
diabetes nurse. Insulin
In general, I have found that patients with type 1 diabetes
know more about the disease than those with type 2 diabetes. For patients
prescribed
insulin, I find out how they use it (eg, changing injection sites).
I look at basics, such as if they have any difficulties using their
device and if they know how to make adjustments to diet or insulin
dosage according to blood glucose readings as well as in illness, trauma
or stress.
One patient had readings over 10mmol/L in the mornings,
and I found she was injecting her long-acting insulin with a short-acting
one each morning. I referred her to her GP practice. I advise patients
with uncontrolled diabetes to record readings in a “diabetes
diary” to discuss with their GP.
MUR form
The MUR form is being revised by the Pharmaceutical
Services Negotiating Committee and the Department of Health,
and a new
form is expected
soon.
The question “is the medicine working?” will
not appear on the new form. |
For patients prescribed glucagon
for hypoglycaemia, I might put “check
the expiry date” as an action point on the MUR form. I have noticed
that many patients dependent on insulin have not heard of sharps bins.
Although lancets and test strips are not medicines, checking the patient’s
use of these is appropriate in an MUR. Some patients who are not on insulin
believe they have to check their blood glucose every day when a once
or twice weekly check should be sufficient (and would save on prescribing
costs). On the other hand, I have come across patients using the same
lancet for weeks, increasing their risk of infection.
For patients who use a blood glucose meter, it is worth checking that
they calibrate it. Some patients do not know about control solution or
where to get it so I note the telephone number for the manufacturer on
their copy of the MUR form. (If a patient’s meter is old, some
companies also provide a new one free of charge.) Many patients who do
not use insulin would like to learn how to interpret their blood glucose
levels and some report that readings are an incentive to live a healthier
lifestyle.
An MUR is also an opportunity to talk about over-the-counter products
and their sugar content. I have found that some patients do not look
at the sugar content of medicines or do not know that sugar-free versions
are available.
I usually record any advice I have given on the MUR form, even though
there is no designated section. My employer provides patient information
leaflets about cholesterol, blood pressure, smoking cessation and weight
management, but a wider range of free leaflets is available to pharmacists
in Norfolk from www.heron.nhs.uk
A general question I ask patients is whether they have a regular diabetes
check-up. I also ask about physical activity and smoking status and note
possible actions for the patient on the action plan page. Diabetes is
a strong risk factor for cardiovascular disease so I also check if the
patient has had a CVD risk assessment. Other risk factors may necessitate
the prescribing of aspirin, statins or angiotensin-converting enzyme
inhibitors.
Diabetes is a complex condition. I completed a Centre for Pharmacy Postgraduate
Education learning pack on the condition about three years ago and trained
to measure blood glucose when I worked for Lloydspharmacy (as part of
a campaign to offer free diabetes checks to every customer). However,
I revised my background knowledge before starting MURs and am still learning
as I go along.
Knowing how to measure blood glucose helps me talk to patients. I recommend
pharmacists learn how to do so from a representative from a blood glucose
machine manufacturer, a diabetes nurse or a friendly patient. On a few
occasions, I have measured blood pressure during an MUR but this and
measuring blood glucose are far above service requirements.
A good knowledge of the possible complications of diabetes is needed.
For example, pharmacists might be asked about preventing diabetic acidosis.
During one MUR, I discovered the patient had been taking co-codamol for “nerve
pain” for months when tricyclic antidepressants are first choice
for painful diabetic neuropathy. Conclusion
Performing MURs has allowed me to identify problems
that would have otherwise gone unnoticed. I am pleased to have the
extra opportunity to ensure
patients have the correct information and understanding about their
medicines. I have found it helpful when colleagues have shared their
experiences. I hope this article will help pharmacists with their
service provision. |